PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378554
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378554
The global neonatal and preterm infants enteral feeding devices market is estimated to be valued at US$ 3.25 Billion in 2023 and is expected to exhibit a CAGR of 5.1% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 3.25 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 5.10% | 2030 Value Projection: | US$ 4.6 Bn |
Neonatal and preterm infants enteral feeding devices are used to deliver nutrients through a tube for pediatric patients with poor voluntary intake, chronic neurological or mechanical dysphagia, or gut dysfunction. The increasing prevalence of chronic disorders in infants is expected to propel the growth of the global neonatal and preterm infant enteral feeding devices market over the forecast period. Furthermore, the increasing preterm birth rate along with the increasing prevalence of chronic disorders in infants is also expected to aid in the growth of the market Enteral nutrition, also known as tube feeding, is a technique to deliver nutrients through a tube if a patient cannot swallow. Depending on the entry point of the tube in the body, enteral nutrition is classified in the following ways: nasogastric tube and gastrostomy or Percutaneous Endoscopic Gastrostomy (PEG) tube. Nutritional support in the preterm includes preventing feeding-related morbidities. Nutritional management in neonatal units across networks often lacks uniformity, both between and within units. Although there is uncertainty in some areas of nutritional support in preterm infants, standardization of practice across networks is associated with a reduced incidence of NEC.
Increasing product approvals by regulatory authorities are expected to drive the global neonatal and preterm infants enteral feeding devices market growth over the forecast period. For instance, in February 2021, Amsino International, Inc., a medical device company, announced that it had received U.S. Food and Drug Administration (FDA) approval for its Puggle Enteral Feeding Pump and Set. The PUGGLE Enteral Feeding Pump and Feeding Set are intended to deliver nutrition to both the pediatric and adult feeding tube patient population.
Global Neonatal And Preterm Infants Enteral Feeding Devices Market Detailed Segmentation: